Here you find Investor News of year 2002.
Ad-hoc messages issued in year 2002 can be found here.
Publications of the previous years are offered in the Archive Overview.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
Receive our IR news via E-Mail, RSS Feed or SMS.
December 20, 2002 | Bayer reaches agreement with U.S. authoritiesPI_20021220_e.pdf |
December 16, 2002 | FDA Approves Once-Daily Cipro® XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs)UCiproXR20021216_e.pdf |
December 6, 2002 | Plans for the future of Pharmaceuticals have the support of the Supervisory BoardNews_20021206_e.pdf |
December 5, 2002 | Strategic options for Rhein Chemie under reviewRC_021205_e.pdf |
December 5, 2002 | New rules for Corporate GovernanceCorpGov_20021205_e.pdf |
December 2, 2002 | Bayer and GlaxoSmithKline: Two New Studies on Erectile Dysfunction PresentedVardenafil021202_e.pdf |
November 29, 2002 | Acarbose - Findings of the first large-scale studyAcarbosestudy_20021129_e.pdf |
November 22, 2002 | Vardenafil Receives Positive Opinion from European Committee for Proprietary Medicinal ProductsLevitra_20021122_e.pdf |
November 13, 2002 | Bayer CropScience to sell additional products to Makhteshim-AganBCS_20021113_e.pdf |
November 12, 2002 | Q3 2002 StatementQ3_2002_e_web.pdf |
November 11, 2002 | Bayer sells household insecticides for EUR 725 million to SC JohnsonHousehold20021111_e.pdf |
October 30, 2002 | Bayer Submits Additional New Drug Application For Once-Daily Cipro XR in U.S.CiproXR_20021030_e.pdf |
October 28, 2002 | Rolf Classon Appointed Chairman of the Board of Management of Bayer HealthCare AGClasson20021028_e.pdf |
October 28, 2002 | Bayer CropScience AG to sell a range of products to BASFFipronil20021028_e.pdf |
October 28, 2002 | Bayer's Cipro Patent Affirmed by U.S. CourtsCipro20021028_e.pdf |
October 16, 2002 | Bayer and SC Johnson have signed Letter of IntentHI_LetterofIntent_20021016_e.pdf |
October 4, 2002 | Bayer plans to sell Rhein Chemie to Advent Internationalrc_021004_e.pdf |
October 2, 2002 | Bayer CropScience agrees to products divestments to Makhteshim-AganBayer bcs_goltix_20021002_e.pdf |
October 1, 2002 | Approval of 200 liter fermenters for Kogenate increases production capacity for the U.S.kg200_20021001_e.pdf |
October 1, 2002 | Bayer CropScience becomes first legally independent subgroupbcs20021001_e.pdf |
October 1, 2002 | Study Comparing Once-Daily Cipro XR to Conventional Twice-Daily Ciprociproxr_20021001_e.pdf |
September 23, 2002 | ISSIR Congress: New Vardenafil Dataissir-2002-e.pdf |
September 18, 2002 | Bayer CropScience agrees to sell wheat herbicide to Arvesta Corporationeverest_20020918_e.pdf |
September 12, 2002 | Bayer cuts a further 4,700 jobs worldwidear_20020912_e.pdf |
August 27, 2002 | New Immune Globulin Intravenous Treatment for Approval in Key Global Markets SubmittedGammunex_200208_e.pdf |
August 15, 2002 | Pharmaceuticals Division signs declaration of intent to market telmisartantelmisartan_200208_e.pdf |
August 01, 2002 | Stockholder's Newsletter 2002: Interim Report for the First Half1h2002_e.pdf |
July 24, 2002 | Bayer agrees to acquire Visible Genetics Inc. for US$ 61.4 millionvgi_20020724_e.pdf |
July 24, 2002 | FDA approvable letter for Vardenafilvardenafil020724_e.pdf |
July 17, 2002 | Bayer plans to sell Haarmann & Reimer to EQTdivest_hr_200207_e.pdf |
June 03, 2002 | Bayer CropScience ready for launchacs_closing_internet_e.pdf |
May 31, 2002 | Bayer to keep fibers businessfasern_20020531_e.pdf |
May 31, 2002 | FTC gives the green light for Bayer to acquire Aventis CropScienceacs-ftc-entscheidung_200205_e.pdf |
May 30, 2002 | Bayer sells stake in Agfa-Gevaertagfa020530_e.pdf |
May 22, 2002 | Bayer taking additional steps to realign cost base of Pharmaceutical Businesspharma020522_e.pdf |
May 21, 2002 | New BAY 43-9006 Phase I data presented at 2002 ASCO meetingonyx_asco_e.pdf |
May 13, 2002 | New EUR 170 million TDA planttda_dormagen_e.pdf |
May 02, 2002 | Avalox i.v. approved in Germany: noticeable drop in treatment costs possibleavelox_iv_deutschland_e.pdf |
April 26, 2002 | Information for Stockholders 2002: Interim Report for the First Quarter1Q2002_e.pdf |
April 25, 2002 | Moxifloxacin IV Reduces Healthcare Costs and Provides Excellent Outcome for Patients hospitalized with Community-Acquired Pneumoniaavelox_200204_e.pdf |
April 17, 2002 | Bayer divests generics business in Spainbayvit_e.pdf |
April 17, 2002 | European Commission clears planned transaction:Bayer can acquire Aventis CropScienceacs-eu-entscheidung_20020417_e.pdf |
April 15, 2002 | New Bayer management team now completeneue_mannschaft_200204_e.pdf |
April 04, 2002 | Bayer Pharma France sells generics business to Tevateva_bayer_classics_e.pdf |
March 25, 2002 | Bayer's euro bonds a resounding successpi_bond_e.pdf |
March 13, 2002 | Bayer expects much higher net income in 2002FY2001_e.pdf |
March 12, 2002 | Bayer plans to divest household insecticidesdivest_household_insecticides_e.pdf |
March 08, 2002 | Bayer Corporation Submits New Drug Application for Once-Daily Formulation of Ciprofloxacin HCI and Ciprofloxacinciprood_nda_release_e.pdf |
March 07, 2002 | Klaus Kühn and Dr. Richard Pott appointed to the Bayer Management Boardar020307_e.pdf |
March 07, 2002 | Bayer to pay dividend of EUR 0.90 per sharedividende02_e.pdf |
March 06, 2002 | Active ingredient in Aspirin reduces the risk of myocardial infarction and strokeaspirin_meta_e.pdf |
February 26, 2002 | Patients Reported Vardenafil Significantly Improved Erectile Function Following Radical Prostatectomyeau2002_e.pdf |
February 20, 2002 | Bayer and Aventis Sign Letter of Intent on Joint Venture of Blood Plasma Businessbiologicals_e.pdf |
February 05, 2002 | Bayer receives offer for generics business in Francegenerika_e.pdf |
January 31, 2002 | Bayer and GlaxoSmithKline Announce: EMEA Acceptance of Regulatory Filing for Vardenafilvardenafil-eu-zulassung-e.pdf |
January 24, 2002 | Bayer stock makes its debut on the New York Stock Exchangebellring020124_e.pdf |
January 22, 2002 | "New" Bayer Group will be more flexible to boost competitiveness and performancenyse020122_e.pdf |
January 11, 2002 | Syngenta and Bayer reach agreement on patent disputesthiamethoxam_e.pdf |
January 09, 2002 | Dr. Wolfgang Plischke appointed new General Manager of the Pharmaceuticals Business Groupph_020109_e.pdf |
January 09, 2002 | Bayer and Burrill & Company form diagnostics capital fundburrildiag_e.pdf |
